Stryker Corp (SYK) stock
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/306% below fair value
$318.15+0.61 (+0.19%)
Close on Nov 18, 2026Market cap $121.12BP/E 33.9Yield –
Stryker operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Stryker's operating cash flow for the twelve months ending Sep 30, 2026 was $5.45B, up 12.7% year over year. For fiscal 2025 it was $5.04B, up 18.9% from the year before. Over ten years it grew 17.8% a year on average. The highest annual figure on record is $5.04B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.04B | +18.9% |
| FY2024 | Dec 31, 2024 | $4.24B | +14.3% |
| FY2023 | Dec 31, 2023 | $3.71B | +41.4% |
| FY2022 | Dec 31, 2022 | $2.62B | -19.6% |
| FY2021 | Dec 31, 2021 | $3.26B | -0.4% |
| FY2020 | Dec 31, 2020 | $3.28B | +49.6% |
| FY2019 | Dec 31, 2019 | $2.19B | -16.1% |
| FY2018 | Dec 31, 2018 | $2.61B | +67.4% |
| FY2017 | Dec 31, 2017 | $1.56B | -18.6% |
| FY2016 | Dec 31, 2016 | $1.92B | +95.2% |
| FY2015 | Dec 31, 2015 | $981.00M | -44.9% |
| FY2014 | Dec 31, 2014 | $1.78B | -5.5% |
| FY2013 | Dec 31, 2013 | $1.89B | +13.8% |
| FY2012 | Dec 31, 2012 | $1.66B | +15.6% |
| FY2011 | Dec 31, 2011 | $1.43B | -7.3% |
| FY2010 | Dec 31, 2010 | $1.55B | +5.9% |
| FY2009 | Dec 31, 2009 | $1.46B | +24.2% |
| FY2008 | Dec 31, 2008 | $1.18B | +14.4% |
| FY2007 | Dec 31, 2007 | $1.03B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.46B | -5.1% |
| Q2 FY2026 | Jun 30, 2026 | $1.26B | +13.5% |
| Q1 FY2026 | Mar 31, 2026 | $581.00M | +132.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.14B | +11.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.54B | +4.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.11B | +75.5% |
| Q1 FY2025 | Mar 31, 2025 | $250.00M | +22.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.93B | +26.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.47B | +40.4% |
| Q2 FY2024 | Jun 30, 2024 | $633.00M | -8.0% |
| Q1 FY2024 | Mar 31, 2024 | $204.00M | -54.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.53B | +52.3% |
| Q3 FY2023 | Sep 30, 2023 | $1.05B | +18.1% |
| Q2 FY2023 | Jun 30, 2023 | $688.00M | +30.1% |
| Q1 FY2023 | Mar 31, 2023 | $445.00M | +119.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.00B | +0.3% |
| Q3 FY2022 | Sep 30, 2022 | $889.00M | -4.7% |
| Q2 FY2022 | Jun 30, 2022 | $529.00M | -39.7% |
| Q1 FY2022 | Mar 31, 2022 | $203.00M | -55.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.00B | -19.2% |
| Q3 FY2021 | Sep 30, 2021 | $933.00M | +12.5% |
| Q2 FY2021 | Jun 30, 2021 | $878.00M | +41.6% |
| Q1 FY2021 | Mar 31, 2021 | $452.00M | -23.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.24B | +68.3% |
| Q3 FY2020 | Sep 30, 2020 | $829.00M | +31.8% |
| Q2 FY2020 | Jun 30, 2020 | $620.00M | +20.6% |
| Q1 FY2020 | Mar 31, 2020 | $591.00M | +88.8% |
| Q4 FY2019 | Dec 31, 2019 | $735.00M | -29.7% |
| Q3 FY2019 | Sep 30, 2019 | $629.00M | +1.8% |
| Q2 FY2019 | Jun 30, 2019 | $514.00M | -20.8% |
| Q1 FY2019 | Mar 31, 2019 | $313.00M | +5.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.05B | +54.1% |
| Q3 FY2018 | Sep 30, 2018 | $618.00M | +682.3% |
| Q2 FY2018 | Jun 30, 2018 | $649.00M | -0.2% |
| Q1 FY2018 | Mar 31, 2018 | $297.00M | +96.7% |
| Q4 FY2017 | Dec 31, 2017 | $679.00M | +3.2% |
| Q3 FY2017 | Sep 30, 2017 | $79.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $650.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $151.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $658.00M | – |
See a number that looks wrong?